Glucagon - Early breakthroughs and recent discoveries

Peptides

Volumn 67, Issue , 2015, Pages 74-81

  Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Diabetes; Glucagon; Glucose; History

Indexed keywords

GLUCAGON; GLUCAGON RECEPTOR; PREPROGLUCAGON; SOMATOSTATIN; GLUCOSE;

BODY WEIGHT; CYTOLOGY; ENERGY EXPENDITURE; GENE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLUCAGONEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CARBOHYDRATE METABOLISM; HISTORY; METABOLISM; PHYSIOLOGY;

ANIMALS; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, TYPE 2; GLUCAGON; GLUCOSE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPOGLYCEMIA; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84926501101     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2015.03.011     Document Type: Review

References (85)

1. J. von Mering, and O. Minkowski Diabetes mellitus nach Pankreasextirpation Arch Exp Pathol Pharmakol 26 1890 371 378
2. J.R. Murlin, H.D. Clough, C.B.F. Gibbs, and A.M. Stokes Aqueous extracts of the pancreas. I. Influence on the carbohydrate metabolism of depancreatized animals J Biol Chem 56 1923 253 296
3. C.P. Kimball, and J.R. Murlin Aqueous extracts of pancreas. III. Some precipitation reactions of insulin J Biol Chem 58 1923 337 346
4. M. Bürger, and W. Brandt Über das Glukagon (die Hyperglykamisierende Substanz des Pancreas) Z Ges Exp Med 96 1935 375
5. E.W. Sutherland, and C. de Duve Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas J Biol Chem 175 1948 663 674
6. A. Staub, L. Sinn, and O.K. Behrens Purification and crystallization of hyperglycemic glycogenolytic factor (HGF) Science 117 1953 628 629
7. A. Staub, L. Sinn, and O.K. Behrens Purification and crystallization of glucagon J Biol Chem 214 1955 619 632
8. W.W. Bromer, L.G. Sinn, A. Staub, and O.K. Behrens The amino acid sequence of glucagon Diabetes 6 1957 234 238
9. G.I. Bell, R. Sanchez-Pescador, P.J. Laybourn, and R.C. Najarian Exon duplication and divergence in the human preproglucagon gene Nature 304 1983 368 714
10. J.J. Holst, M. Bersani, A.H. Johnsen, H. Kofod, B. Hartmann, and C. Orskov Proglucagon processing in porcine and human pancreas J Biol Chem 269 1994 18827 18833
11. J.J. Holst Thye physiology of glucagon-like peptide 1 Physiol Rev 87 2007 1409 1439
12. G.A. Robison, R.W. Butcher, and E.W. Sutherland Cyclic AMP Ann Rev Biochem 37 1968 149 174
13. J.H. Exton, and C.R. Park The role of cyclic AMP in the control of liver metabolism Adv Enzyme Regul 6 1968 391 407
14. M. Rodbell The complex regulation of receptor-coupled G-proteins Adv Enzyme Regul 37 1997 427 435
15. R.H. Unger, A.M. Eisentraut, M.S. McCall, and L.L. Madison Glucagon antibodies and immunoassay for glucagon J Clin Investig 40 1961 1280 1289
16. B. Ahrén, and I. Lundquist Glucagon immunoreactivity in plasma from normal and dystrophic mice Diabetologia 22 1982 258 263
17. N.J. Wewer Albrechtsen, B. Hartmann, S. Veedfald, J.A. Windeløv, A. Plamboeck, and K.N. Bojsen-Møller Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? Diabetologia 57 2014 1919 1926
18. R. Burgus, N. Ling, M. Cutcher, and R. Guillemin Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone Proc Natl Acad Sci USA 70 1973 684 688
19. D. Koerker, W. Ruch, E. Chideckel, J. Palmer, C.J. Goodner, and J. Ensinck Somatostatin: hypothalamic inhibitor of the endocrine pancreas Science 184 1974 482 484
20. J.E. Gerich, M. Lorenzi, V. Schneider, J.H. Karam, J. Rivier, and R. Guillemin Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications N Engl J Med 291 1973 544 547
21. R.W. Gelling, X.Q. Du, D.S. Dichmann, J. Romer, H. Huang, and L. Cui Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice Proc Natl Acad Sci USA 100 2003 1438 1443
22. C. Hellerström A method for the microdissection of intact pancreatic islets of mammals Acta Endocrinol 45 1964 122 132
23. P.E. Lacy, and M. Kostianovsky Method or the isolation of intact islets of Langerhans from the rat pancreas Diabetes 16 1967 35 39
24. A.D. Cherrington Control of glucose uptake and release by the liver in vivo Diabetes 48 1999 1198 1214
25. J.E. Liljenquist, G.L. Mueller, A.D. Cherrington, U. Keller, J.L. Chiasson, and J.M. Perry Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man J Clin Investig 39 1977 369 374
26. R.H. Unger, and A.D. Cherrington Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover J Clin Investig 122 2012 4 12
27. P. Shah, A. Vella, A. Basu, R. Basu, W.F. Schwenk, and R.A. Rizza Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes J Clin Endocrinol Metab 85 2000 4053 4059
28. J.E. Gerich, V. Schneider, S.E. Dippe, M. Langlois, C. Noacco, and J. Karam Characterization of the glucagon response to hypoglycemia in man J Clin Endocrinol Metab 38 1974 77 82
29. G.B. Bolli, G.D. Dimitriadis, G.B. Pehling, B.A. Baker, M.W. Haymond, and P.E. Cryer Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus N Engl J Med 310 1984 1706 1711
30. P.E. Cryer Glucose counterregulation in man Diabetes 30 1981 261 264
31. S. Malmgren, and B. Ahrén DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice Diabetologia 2015 [in press] (PMID:25660260)
32. B. Ahrén Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes Vasc Health Risk Manag 9 2013 155 163
33. B. Ahrén, and G.J. Taborsky Jr. The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog Endocrinology 118 1986 1551 1557
34. B. Ahrén, R.C. Veith, and G.J. Taborsy Jr. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: (1) Effects on basal release of insulin and glucagon Endocrinology 121 1987 323 331
35. B. Ahrén Autonomic regulation of islet hormone secretion - implications for health and disease Diabetologia 43 2000 393 410
36. P.J. Havel, J.O. Akpan, D.L. Curry, J.S. Stern, R.L. Gingerich, and B. Ahrén Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglycopenia and hyopoglycemia in mice Am J Physiol 265 1993 R246 R254
37. P.J. Havel, and B. Ahrén Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women Diabetes 46 1997 801 807
38. M. Christensen, L. Vedtofte, J.J. Holst, T. Vilsboll, and F.K. Knop Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans Diabetes 60 2011 3103 3109
39. E. Samols, J.I. Stagner, R.B. Ewart, and V. Marks The order of islet microvascular cellular perfusion is B-A-D in the perfused rat pancreas J Clin Investig 82 1988 350 353
40. S. Xu, E. Dror, F. Schulze, T. Nordmann, S. Häuselmann, and F. Thorel Alpha cell derived glucagon-related peptides are required for normal beta cell function and glucose homeostasis 6th Annual Meeting of the European Association for the Study of Diabetes 2014 [abstract 614]
41. D.G. Pipeleers, F.C. Schuit, P.A. in't Veld, E. Moes, E.L. Hooghe-Peters, and M. van de Winkel Interplay of nutrients and hormones in the regulation of insulin release Endocrinology 117 1995 824 833
42. P. Marchetti, R. Lipi, M. Bguliani, C.L. Kirkpatrick, G. Sebastiani, and F.A. Greco A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets Diabetologia 55 2012 3262 3272
43. B. Ahrén, R. Håkanson, I. Lundquist, K. Sjölund, and F. Sundler GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release Acta Physiol Scand 112 1981 233 242
44. H. Sørensen, M.S. Winzell, C.L. Brand, K. Fosgerau, R.W. Gelling, and E. Nishimura Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function Diabetes 55 2006 3463 3469
45. B. Omar, M. Sörhede-Winzell, and B. Ahrén Conditional glucagon receptor overexpression has multi-faced consequences for beta-cell function Metabolism 63 2014 1568 1576
46. R.H. Unger, and K.L. Orci The essential role of glucagon in the pathogenesis of diabetes mellitus Lancet 1 1975 14 16
47. W.A. Müller, G.R. Faloona, E. Aquilar-Parada, and R.H. Unger Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion N Engl J Med 283 1970 109 115
48. A. Lund, J.L. Bagger, M. Christensen, F.K. Knop, and T. Vilsboll Glucagon and type 2 diabetes: the return of the alpha cell Curr Diabetes Rep 14 2014 555
49. B. Ahrén, M. Landin-Olsson, P.A. Jansson, M. Svensson, D. Holmes, and A. Schweizer Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes J Clin Endocrinol Metab 89 2004 2075 2084
50. B. Ahrén, J.F. Gautier, R. Berria, W. Stager, R. Aronson, and C.J. Bailey Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials Diabetes Obes Metab 16 2014 861 868
51. H. Larsson, G. Berglund, and B. Ahrén Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance J Clin Endocrinol Metab 80 1995 1778 1782
52. H. Larsson, and B. Ahrén Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women Diabetologia 43 2000 194 202
53. B. Ahrén Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women Diabetes 58 2009 726 731
54. M. Matsuda, R. DeFronzo, L. Glass, A. Consoli, M. Giordano, and P. Bressler Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals Metabolism 51 2002 1111 1119
55. J.C. Henquin, and J. Rahier Pancreatic alpha cell mass in European subjects with type 2 diabetes Diabetologia 54 2011 1720 1725
56. Y. Lee, M.Y. Wang, X.Q. Du, M.J. Charron, and R.H. Unger Glucagon receptor knockout prevents non-insulin-deficient type 1 diabetes in mice Diabetes 60 2011 391 397
57. B.A. Omar, B. Andersen, J. Hald, K. Rain, E. Nishimura, and B. Ahrén Fibroblast growth factor 21 (FGF-21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice Diabetes 63 2014 101 110
58. L.S. Jun, R.L. Millican, E.D. Hawkins, D.L. Konkol, A.D. Showalter, and M.E. Christe Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production Diabetes 64 2015 819 827
59. M. Gutniak, C. Orskov, J.J. Holst, B. Ahrén, and S. Efendic Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus N Engl J Med 326 1992 1316 1322
60. M.A. Nauck, N. Kleine, C. ∅rskov, J.J. Holst, B. Willms, and W. Creutzfeldt Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36)amide in type 2 (non-insulin-dependent) diabetic patients Diabetologia 36 1993 741 744
61. J.I. Bagger, F.K. Knop, J.J. Holst, and T. Vilsbøll Glucagon antagonism as a potential therapeutic target in type 2 diabetes Diabetes Obes Metab 13 2011 965 971
62. U. Kielgast, J.J. Holst, and S. Madsbad Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function Diabetes 60 2011 1599 1607
63. J. Farngren, M. Persson, A. Schweizer, J.E. Foley, and B. Ahrén Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes J Clin Endocrinol Metab 97 2012 3799 3806
64. K.M. Habegger, K.M. Heppner, N. Geary, T.J. Bartness, R. DiMarchi, and M.H. Tschöp The metabolic actions of glucagon revisited Nat Rev Endocrinol 6 2010 689 697
65. J.C. Henquin, D. Accdili, B. Ahrén, C. Boitard, S. Seino, and E. Cerasi Long in the shade, glucagon re-occupies centre court Diabetes Obes Metab 13 Suppl. 1 2011 5 7
66. B.A. Omar, L. Liehua, Y. Yamada, Y. Seino, P. Marchetti, and B. Ahrén Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes Diabetologia 57 2014 1876 1883
67. A.M. Hansen, T.B. Bodvarsdottir, D.N. Nordestgaard, R.S. Heller, C.F. Gotfredsen, and K. Maedler Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus - an adaptive response to hyperglycaemia? Diabetologia 54 2011 1379 1387
68. L. Liu, B. Omar, P. Marchetti, and B. Ahrén Dipeptidyl peptidase-4 (DPP-4): localization and activity in human and rodent islets Biochem Biophys Res Commun 453 2014 398 404
69. B. Omar, and B. Ahrén Pleiotropic mechanisms for the glucose-lowering action of DPP-4 inhibitors Diabetes 63 2014 2196 2202
70. F. Tjorel, V. Népote, I. Avril, K. Kohno, R. Desigraz, and S. Chena Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss Nature 464 2010 1149 1154
71. M.F. Brereton, M. Iberl, K. Shimomura, Q. Zhang, A.E. Adriaenssens, and P. Proks Reversible changes in pancreatic islet structure and function produced by elevated blood glucose Nat Commun 5 2014 4639
72. N.C. Bramswig, L.J. Everett, J. Schug, C. Dorrell, C. Liu, and Y. Luo Epigenomic plasticity enables human pancreatic α to β cell reprogramming J Clin Investig 123 2013 1275 1284
73. B. Ahrén, G.J. Taborsky Jr., and P.J. Havel Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice Metabolism 51 2002 12 19
74. E. Ferrannini, E. Muscelli, S. Francerra, S. Baldi, A. Mari, and T. Heise Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients J Clin Investig 124 2014 499 508
75. A. Merovci, C. Solis-Herrera, G. Daniele, R. Eldor, T.V. Fiorentino, and D. Tripathy Dapagliflozin improves muscle sensitivity but enhances endogenous glucose production J Clin Investig 124 2014 509 514
76. J.J. Meier, M.A. Nauck, A. Pott, K. Heinze, O. Goetze, and K. Bulul Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans Gastroenterology 130 2007 44 54
77. C.B. Burness, and P.L. McCormack Teduglutide: a review of its use in the treatment of patients with short bowel syndrome Drugs 73 2013 935 947
78. M. Salehi, A. Gastaldelli, and D.A. D'Alessio Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia J Clin Endocrinol Metab 99 2014 2008ä-2017
79. T.M. Tan, B.C. Field, K.A. McCullough, R.C. Troke, E.S. Chambers, and V. Salem Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia Diabetes 62 2013 1131 1138
80. D.J. Drucker, and S. Asa Glucagon gene expression in vertebrate brain J Biol Chem 263 1998 13475 13478
81. R.V. Campos, Y.C. Lee, and D.J. Drucker Divergent tissue-specific developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse Endocrinology 134 1994 2159 2164
82. P.I. Mighiu, J.T. Yue, B.M. Filippi, M.A. Abraham, M. Chari, and C.K. Lam Hypothalamic glucagon signaling inhibits hepatic glucose production Nat Med 19 2013 766 772
83. J. Cegla, R.C. Troke, B. Jones, G. Tharakan, J. Kenkre, and K.A. McCullough Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake Diabetes 63 2014 3711 3720
84. N.C. Geething, W. To, B.J. Spink, M.D. Scholle, C.W. Wang, and Y. Yin Gcg-XTEN: an improved glucagon capable of preventing hypoglycemia without increasing baseline blood glucose PLoS ONE 5 2010 10175
85. K. Miller, A. Kim, G. Kilimnik, J. Jo, U. Moka, and V. Periwal Islet formation during the neonatal development in mice PLoS ONE 4 2009 e7739